Kathi Niffenegger
2017
In 2017, Kathi Niffenegger earned a total compensation of $260.8K as Chief Financial Officer and Corporate Secretary at Edesa Biotech, a 19% decrease compared to previous year.
Compensation breakdown
| Bonus | $20,000 |
|---|---|
| Option Awards | $19,744 |
| Salary | $202,560 |
| Other | $18,526 |
| Total | $260,830 |
Niffenegger received $202.6K in salary, accounting for 78% of the total pay in 2017.
Niffenegger also received $20K in bonus, $19.7K in option awards and $18.5K in other compensation.
Rankings
In 2017, Kathi Niffenegger's compensation ranked 13,626th out of 14,666 executives tracked by ExecPay. In other words, Niffenegger earned more than 7.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,626 out of 14,666 | 7th |
Division Manufacturing | 5,351 out of 5,768 | 7th |
Major group Chemicals And Allied Products | 1,931 out of 2,074 | 7th |
Industry group Drugs | 1,613 out of 1,730 | 7th |
Industry Pharmaceutical Preparations | 1,235 out of 1,329 | 7th |
Source: SEC filing on February 13, 2018.
Niffenegger's colleagues
We found two more compensation records of executives who worked with Kathi Niffenegger at Edesa Biotech in 2017.
News
Edesa Biotech CEO Pardeep Nijhawan's 2023 pay slips 9% to $550K
April 5, 2024
Edesa Biotech CEO Pardeep Nijhawan's 2022 pay falls 54% to $602K
March 28, 2023
Edesa Biotech CEO Pardeep Nijhawan's 2021 pay jumps 221% to $1.3M
April 1, 2022
Edesa Biotech President Michael Brooks' 2020 pay jumps 155% to $529K
March 3, 2021
Edesa Biotech President Michael Brooks' 2019 pay slips 10% to $207K
March 23, 2020